Schedule 13G ownership disclosure

ALX Oncology Holdings, Inc.

Common Stock, par value $0.001 per share · CUSIP: 00166B105

Event date: 2026-01-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP II, LLC

    Shares: 6,505,925 · Class: 5.0%

  • TCG Crossover Fund II, L.P.

    Shares: 6,505,925 · Class: 5.0%

  • TCG Crossover GP III, LLC

    Shares: 6,505,924 · Class: 5.0%

  • TCG Crossover Fund III, L.P.

    Shares: 6,505,924 · Class: 5.0%

  • Chen Yu

    Shares: 13,011,849 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-041306
Form type
SCHEDULE 13G
Filer
ALX ONCOLOGY HOLDINGS INC
CIK
CIK 1810182
Filed
Feb 06, 2026
Reporting period
Jan 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub